Related references
Note: Only part of the references are listed.Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence
Valeria Avataneo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial
Rosa L. de Jager et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Risk Factors for Nonadherence to Antihypertensive Treatment
Pankaj Gupta et al.
HYPERTENSION (2017)
Current Situation of Medication Adherence in Hypertension
Bernard Vrijens et al.
FRONTIERS IN PHARMACOLOGY (2017)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams et al.
LANCET (2015)
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry ( HP LC-MS/MS) urine analysis
Maciej Tomaszewski et al.
HEART (2014)
Therapeutic effects of motivational interviewing on blood pressure control: A meta-analysis of randomized controlled trials
Yanping Ren et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
A meta-analysis of the association between adherence to drug therapy and mortality
Scot H. Simpson et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Share Paper
